A thin layer chromatography identification method for the index components in Kaixinsan
Through solution ultrasonic extraction and the use of specific developer, combined with negative test sample solution, efficient identification of multiple index components in Kaixinsan was achieved, and the problem of low identification efficiency in the prior art was solved, and a clear chromatography was obtained The diagram and good separation meet the actual production needs.
Patent Information
- Application Number
- CN202411120819.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-15
AI Technical Summary
The existing thin-layer analysis methods are difficult to quickly and efficiently identify multiple index components in Kaixinsan, and the complex component structure leads to low identification efficiency and cannot meet the actual production needs.
The test sample solution was prepared by solution ultrasonic extraction, using silica gel G thin-layer plate and dichloromethane-n-butanol-water and dichloromethane-ethyl acetate-formic acid as the developer, combined with the negative test sample solution and the control The medicinal material solution was used to identify ginseng saponins, zoosinosaponins, β-asarum ether, dehydrogenated tumoic acid and poric acid through chromogenic examination.
The success rate and efficiency of Kaixinsan thin layer identification were significantly improved, the chromatogram obtained was clear and the resolution was good, which met the requirements for Kaixinsan's identification efficiency in actual production, and provided important significance for the quality control of Poria cocos and Acorus granulis medicinal materials.
Smart Images

Figure CN118624803B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical fields of pharmaceutical raw material detection technology and traditional Chinese medicine quality control technology, and particularly relates to a thin layer identification method for index components in Kaixin powder. Background Art
[0002] The classic prescription Kaixinsan comes from "Prescriptions for Emergencies Worth a Thousand Gold Pieces" by Sun Simiao in the Tang Dynasty. It is composed of four herbs: ginseng, polygala, poria and calamus. It has the effects of invigorating qi and nourishing the heart, calming the mind and settling the spirit. It is mainly used to treat symptoms such as insufficient heart qi, restlessness, forgetfulness and insomnia.
[0003] At present, the identification method of the main index components in Kaixin Powder can adopt liquid chromatography and thin layer analysis method. Liquid chromatography can realize the quantitative analysis of various components under the premise of selecting appropriate fluidity and elution gradient. For example, the patent with publication number CN115267005A uses high performance liquid chromatography to realize the quantitative analysis of five index components in Kaixin Powder, but liquid chromatography has extremely high requirements for equipment, the operation process requires a high level of technology and professional knowledge, and the requirements for experimental conditions are also relatively strict, and the time required is relatively long.
[0004] Thin layer chromatography is an important experimental technique for rapid separation and qualitative analysis of small amounts of substances. The equipment and operation process are relatively simple, and the sample dosage and time are relatively low. However, the existing thin layer chromatography analysis methods are mainly for the analysis of single herbs in Kaixin Powder, and there is no detailed report on the thin layer chromatography identification of the whole Kaixin Powder. The general practice is to identify the four herbs in Kaixin Powder separately according to the thin layer chromatography identification conditions corresponding to each of the four herbs, ginseng, polygala, poria and calamus, which is difficult to meet the requirements for the efficiency of thin layer chromatography identification of Kaixin Powder in actual production. At the same time, the compound ingredients are complex, and the thin layer chromatography analysis method of single herbs cannot accurately eliminate interference. The main active ingredients of ginseng in Kaixinsan include ginsenoside Rb1, ginsenoside Rg1, and ginsenoside Re, Polygala contains indicative ingredients such as Polygala tenuifolia saponins, Poria contains triterpenoid compounds such as pachymic acid and dehydrogenated tert-butyl acid, and Acorus tatarinowii contains volatile oils (such as β-asarone). Due to the large structural differences of the above-mentioned indicative ingredients, the existing technology basically uses specific identification methods and conditions for separate identification, which greatly reduces the efficiency of Kaixinsan's full-form identification. How to achieve efficient identification of multiple indicative ingredients in Kaixinsan with simpler analytical conditions in the thin-layer analysis method is of great significance to the identification and quality control of the characteristic indicative ingredients of Kaixinsan. Summary of the invention
[0005] In view of the above problems, the present invention provides a thin layer identification method for the index components in Kaixin Powder, the method comprising the following steps:
[0006] A sample of Kaixinsan test solution 1, Kaixinsan negative test solution 1, reference medicinal material solution 1, and reference substance solution was placed on a silica gel G thin layer plate 1 to determine the index components in ginseng and polygala;
[0007] The Kaixinsan test solution 2, Kaixinsan negative test solution 2, reference medicinal material solution 2 and reference substance solution 2 were respectively sampled and spotted on silica gel G thin layer plate 2 to determine the index components in Poria cocos and Acorus tatarinowii.
[0008] Develop the silica gel G thin layer plate 1 with dichloromethane-n-butanol-water as a developing solvent, and develop the silica gel G thin layer plate 2 with dichloromethane-ethyl acetate-formic acid as a developing solvent. After development, take out the silica gel G thin layer plate 1 and the silica gel G thin layer plate 2 and dry them;
[0009] After drying, the first silica gel G thin layer plate was sprayed with sulfuric acid ethanol solution for color development inspection, and after drying, the second silica gel G thin layer plate was sprayed with vanillin sulfuric acid ethanol mixed solution for color development inspection.
[0010] Furthermore, the index components in the ginseng and polygala include ginsenoside Rb1, ginsenoside Re and polygala tenuifolia saponin;
[0011] The index components in the Poria cocos and Acorus tatarinowii include β-asarone, dehydrogenated turmeric acid and pachymic acid.
[0012] Further, the Kaixin powder test solution 1 is a Kaixin powder solution with a mass volume ratio of 1 g / 10 mL using 80-95% ultrasonic ethanol dissolution;
[0013] The first negative test solution of Kaixinsan is a 1.5 g / 25 mL Acorus tatarinowii and Poria cocos solution dissolved in 80-95% ethanol; wherein the mass volume ratios of Acorus tatarinowii and Poria cocos in the Acorus tatarinowii and Poria cocos solution are 0.5 g / 25 mL and 1 g / 25 mL respectively;
[0014] The control medicinal material solution 1 includes a polygala control medicinal material solution and a ginseng control medicinal material solution, each of which has a mass volume ratio of 1 g / 50 mL and is ultrasonically dissolved in 80-95% ethanol;
[0015] The reference solution one includes ginsenoside Rb1 reference solution, ginsenoside Re reference solution and polygala tenuifolia saponin reference solution, all of which are dissolved in methanol at a mass volume ratio of 1 mg / 1 mL.
[0016] Furthermore, the Kaixin powder test solution 2 is a Kaixin powder solution with a mass volume ratio of 1 g / 10 mL obtained by ultrasonic dissolution in dichloromethane;
[0017] The second negative test solution of Kaixinsan is a ginseng and polygala solution with a mass volume ratio of 1 g / 25 mL dissolved by ultrasonication in dichloromethane; wherein the mass volume ratio of ginseng and polygala to the ginseng and polygala solution is 0.5 g / 25 mL;
[0018] The second control medicinal material solution includes a control medicinal material solution of Acorus tatarinowii with a mass volume ratio of 1 g / 50 mL and a control medicinal material solution of Poria cocos with a mass volume ratio of 1 g / 25 mL, which are ultrasonically dissolved in dichloromethane;
[0019] The second reference solution includes a β-asarone reference solution, a dehydrogenated tert-butyl ether reference solution and a pachymic acid reference solution dissolved in methanol at a mass volume ratio of 1 mg / 1 mL.
[0020] Furthermore, the sample volume ratio of Kaixinsan test solution 1, Kaixinsan negative test solution 1, control medicinal material solution 1, and reference substance solution 1 is 15:15:8:6;
[0021] The sample spotting volume ratio of Kaixinsan test solution 2, Kaixinsan negative test solution 2, control medicinal material solution 2, and reference substance solution 2 is 15:15:8:6.
[0022] Furthermore, the volume ratio of dichloromethane:n-butanol:water in the dichloromethane-n-butanol-water developing agent is 7-8:4:1, preferably 7:8:1.
[0023] Furthermore, the volume of dichloromethane-ethyl acetate-formic acid in the dichloromethane-ethyl acetate-formic acid developing agent is 12:3:0.25-0.5, preferably 12:3:0.5.
[0024] Furthermore, the mass percentage concentration of the sulfuric acid-ethanol mixed solution is 5%, wherein the volume ratio of the sulfuric acid solution to the ethanol solution is 1:19.
[0025] Furthermore, the mass percentage concentration of the vanillin sulfuric acid ethanol mixed solution is 2%; wherein the volume ratio of the vanillin sulfuric acid solution to the ethanol solution is 1:9.
[0026] Furthermore, the inspection condition is inspection under sunlight or under 365nm ultraviolet light.
[0027] Beneficial effects of the present invention:
[0028] The present invention adopts a solution ultrasonic extraction method. Only two test sample solutions need to be prepared to achieve effective identification of ginsenoside Rb1, ginsenoside Re, Polygala tenuifolia saponin, β-asarone, dehydrogenated turbid acid and pachymic acid in Kaixinsan on two silica gel G thin layer plates. The sample is spotted using an automatic spotter to ensure that the sample is evenly spotted. Then, the silica gel G thin layer plate after the sample is placed in the developing agent steam for pre-saturation, which can ensure that the sample is evenly spotted and the strips in the development process are flat, thereby improving the accuracy of identification. In addition, the present invention sets a negative test sample solution and a control medicinal material solution during the thin layer analysis, so that the chromatogram can be more clearly compared. Through experiments, it is found that the identification method proposed by the present invention has good applicability, the obtained chromatogram is clear, the separation is good, and the success rate of Kaixinsan thin layer identification is significantly improved, which meets the requirements for Kaixinsan identification efficiency in actual production. At the same time, the present invention identified the characteristic components of the thin layer of Poria cocos and Acorus calamus in the 2020 edition of the "Chinese Pharmacopoeia", which is of great significance for the establishment of quality control indicators for Poria cocos and Acorus calamus medicinal materials.
[0029] Other features and advantages of the present invention will be described in the following description, and partly become apparent from the description, or understood by practicing the present invention. The purpose and other advantages of the present invention can be realized and obtained by the structures pointed out in the description, claims and drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0031] Figure 1 The thin layer examination diagram of ginsenoside Rb1, ginsenoside Re and polygala tenuifolia saponin in Kaixin Powder in Example 1 is shown;
[0032] Figure 2 The thin layer examination diagram of β-asarone, dehydrogenated turbid acid and pachymic acid in Kaixin Powder in Example 2 is shown;
[0033] Figure 3 The thin layer examination diagram of ginsenoside Rb1, ginsenoside Re and Polygala tenuifolia saponin in Kaixin Powder in Comparative Example 1-1 is shown;
[0034] Figure 4 The thin layer examination diagram of ginsenoside Rb1, ginsenoside Re and Polygala tenuifolia saponin in Kaixin Powder in Comparative Example 1-2 is shown;
[0035] Figure 5The thin layer examination diagram of ginsenoside Rb1, ginsenoside Re and Polygala tenuifolia saponin in Kaixin Powder in Comparative Examples 1-3 is shown;
[0036] Figure 6 The thin layer examination diagram of ginsenoside Rb1, ginsenoside Re and Polygala tenuifolia saponin in Kaixin Powder in Comparative Examples 1-4 is shown;
[0037] Figure 7 The thin layer examination diagram of β-asarone, dehydrogenated tert-butyl ether and pachymic acid in Kaixin Powder in Example 2-1 is shown;
[0038] Figure 8 The thin layer examination diagram of β-asarone, dehydrogenated tert-butyl ether and pachymic acid in Kaixin Powder in Comparative Example 2-1 is shown;
[0039] Fig. 9 The thin layer examination diagram of β-asarone, dehydrogenated tert-butyl ether and pachymic acid in Kaixin Powder in Comparative Example 2-2 is shown;
[0040] Fig.10 The thin layer examination diagram of β-asarone, dehydrogenated tert-butyl ether and pachymic acid in Kaixin Powder in Comparative Example 2-3 is shown. DETAILED DESCRIPTION
[0041] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0042] Example 1
[0043] This embodiment provides a thin layer identification method for ginsenoside Rb1 and ginsenoside Re in ginseng and polygala tenuifolia saponin in polygala in Kaixinsan, comprising the following steps:
[0044] Preparation of Kaixinsan test solution 1: Take 2.5 g of Kaixinsan powder, add 25 mL of 90% ethanol, ultrasonically treat (power 250 W, frequency 50 kHz) for 45 minutes, filter, evaporate the filtrate to dryness, add 1 mL of methanol to the residue to dissolve it, and use it as Kaixinsan test solution 1.
[0045] Preparation of Kaixinsan negative test solution 1: Take 0.5g of Acorus calamus powder and 1g of Poria cocos powder, add 25mL of 90% ethanol, ultrasonically treat (power 250W, frequency 50kHz) for 45 minutes, filter, evaporate the filtrate to dryness, add 1mL of methanol to dissolve the residue, and use it as Kaixinsan negative test solution 1.
[0046] Preparation of control medicinal material solution 1: Take 0.5 g of Polygala control medicinal material and 0.5 g of ginseng control medicinal material respectively, and prepare the test solution 1 of Kaixin Powder in the same way to obtain Polygala control medicinal material solution and ginseng control medicinal material solution.
[0047] Preparation of reference solution 1: Take ginsenoside Rb1 reference, ginsenoside Re reference, and Polygala tenuifolia saponin reference and add methanol to make 1 mL of each solution containing 1 mg of the reference substance, to obtain ginsenoside Rb1 reference solution, ginsenoside Re reference solution, and Polygala tenuifolia saponin reference solution.
[0048] Spotting: According to the thin layer chromatography method (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0502), take 15μL of the test solution, 15μL of the Kaixinsan negative test solution, 8μL of the control medicinal material solution (8μL each of the Polygala control medicinal material solution and the Ginseng control medicinal material solution), and 6μL of the reference solution (6uL each of the Ginsenoside Rb1 reference solution, the Ginsenoside Re reference solution, and the Polygala tenuifolia saponin reference solution), and spot them on a silica gel G thin layer plate; use an automatic spotter to ensure that the spots are even and level during spotting;
[0049] Development: Use a mixed solution of dichloromethane-n-butanol-water with a volume ratio of 7:4:1 as the developing agent, place the spotted silica gel G thin layer plate in the developing agent vapor for pre-saturation, develop, take out, and dry;
[0050] Inspection: Spray a 5% sulfuric acid ethanol solution (volume ratio of sulfuric acid solution to ethanol solution is 1:19) on the dried silica gel G thin layer plate, heat at 105°C until the spots are clearly colored, and inspect under ultraviolet light (365nm).
[0051] The results are as follows Figure 1 As shown, 1 is ginsenoside Rb1 reference solution; 2 is ginsenoside Re reference solution; 3 is polygala tenuifolia saponin reference solution; 4 is polygala tenuifolia reference medicinal material solution; 5 is ginseng reference medicinal material solution; 6 is Kaixinsan test solution 1; 7 is Kaixinsan negative test solution 1. It can be seen that in the Kaixinsan negative test sample chromatogram, the main spot of the same color appears at the corresponding position of the reference medicinal material chromatogram.
[0052] Example 2
[0053] This embodiment provides a thin layer chromatography identification method for β-asarone and dehydrogenated turmeric acid in Acorus calamus and pachymic acid in Poria cocos in Kaixin Powder, comprising the following steps:
[0054] Preparation of Kaixinsan test solution II: Take 2.5 g of Kaixinsan powder, add 25 mL of dichloromethane, ultrasonically treat (power 250 W, frequency 50 kHz) for 20 minutes, filter, evaporate the filtrate to dryness, add 1 mL of methanol to the residue to dissolve it, and use it as Kaixinsan test solution II.
[0055] Preparation of Kaixinsan negative test solution 2: Take 0.5g of ginseng powder and 0.5g of polygala powder, add 25mL of dichloromethane, ultrasonically treat (power 250W, frequency 50kHz) for 20 minutes, filter, evaporate the filtrate to dryness, add 1mL of methanol to the residue to dissolve it, and use it as Kaixinsan negative test solution 2.
[0056] Preparation of control medicinal solution 2: Take 0.5g of Acorus tatarinowii control medicinal material and 1g of Poria cocos control medicinal material respectively, and prepare the test solution 2 of Kaixin Powder in the same way to obtain Poria cocos control medicinal material solution and Acorus tatarinowii control medicinal material solution.
[0057] Preparation of reference solution 2: Take β-asarone reference, dehydrogenated tert-butyl ester reference, and pachymic acid reference and add methanol to make 1 mL of solution containing 1 mg each, to obtain β-asarone reference solution, dehydrogenated tert-butyl ester reference solution, and pachymic acid reference solution.
[0058] Spotting: According to the thin layer chromatography method (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0502), take 15μL of Kaixinsan test solution 2, 15μL of Kaixinsan negative test solution 2, 8μL of control medicinal material solution 2 (8μL each of Poria control medicinal material solution and Acorus tatarinowii control medicinal material solution), and 6μL of reference substance solution 2 (6μL each of β-asarone reference substance solution, dehydrogenated tert-butyl acid reference substance solution and tuckahoe acid reference substance solution), and spot them on silica gel G thin layer plate 2 respectively; use an automatic spotter to ensure that the spots are even and level during spotting;
[0059] Development: Use a mixed solution of dichloromethane-ethyl acetate-formic acid with a volume ratio of 12:3:0.5 as the developing agent, place the spotted silica gel G thin layer plate in the developing agent vapor for pre-saturation, develop, take out, and dry;
[0060] Inspection: Spray a 2% by mass concentration of vanillin sulfate ethanol (the volume of vanillin sulfate solution and ethanol is 1:9) mixed solution on the dried silica gel G thin layer plate 2, and heat at 105°C until the spots are clearly colored.
[0061] The results are as follows Figure 2As shown, 1 is β-asarone reference solution; 2 is dehydrogenated tert-butyl acid reference solution; 3 is pachymic acid reference solution; 4 is pachycory reference medicinal material solution; 5 is Acorus tatarinowii reference medicinal material solution; 6 is Kaixinsan test solution 2; 7 is Kaixinsan negative test solution 2. It can be seen that in the Kaixinsan negative test sample chromatogram, the main spot of the same color appears at the corresponding position of the reference medicinal material chromatogram, and the separation effect is good.
[0062] Example 1-1
[0063] The same method as in Example 1 was used to perform TLC identification on the index components in Polygala tenuifolia and Ginseng in Kaixin Powder, except that, during the preparation process, 90% ethanol was replaced by 80% ethanol for ultrasonic extraction.
[0064] The results showed that in the chromatogram of the negative test sample of Kaixin Powder, a main spot of the same color appeared at the corresponding position in the chromatogram of the control medicinal material, but the spot was slightly blurred compared to 90% ethanol, but it was still distinguishable.
[0065] Example 1-2
[0066] The same method as in Example 1 was used to perform TLC identification on the index components in Polygala tenuifolia and Ginseng in Kaixin Powder, except that, during the preparation process, 90% ethanol was replaced by 95% ethanol for ultrasonic extraction.
[0067] The results showed that in the chromatogram of the negative test sample of Kaixin Powder, a main spot of the same color appeared at the corresponding position in the chromatogram of the control medicinal material.
[0068] Comparative Example 1-1
[0069] The same method as in Example 1 was used to perform TLC identification on the index components in Polygala tenuifolia and Ginseng in Kaixin Powder, except that, during the preparation process, 90% ethanol was replaced by 70% ethanol for ultrasonic extraction.
[0070] The results are as follows Figure 3 As shown, 1 is ginsenoside Rb1 reference solution; 2 is ginsenoside Re reference solution; 3 is polygala tenuifolia saponin reference solution; 4 is polygala tenuifolia reference medicinal material solution; 5 is ginseng reference medicinal material solution; 6 is Kaixinsan test solution 1; 7 is Kaixinsan negative test solution 1. It can be seen that the development effect is not ideal. At the position corresponding to the reference medicinal material chromatogram, the main color spot is blurred, and the spot is more blurred compared with 90% ethanol ultrasonic extraction.
[0071] Comparative Example 1-2
[0072] The same method as in Example 1 was used to perform TLC identification on the indicative components in Polygala tenuifolia and Ginseng in Kaixin Powder, except that in the developing step, the developing agent was a mixed solution of dichloromethane-n-butanol-water in a mixed volume ratio of 9:4:1.
[0073] The results are as follows Figure 4 As shown, 1 is ginsenoside Rb1 reference solution; 2 is ginsenoside Re reference solution; 3 is Polygala tenuifolia saponin reference solution; 4 is Polygala tenuifolia reference medicinal material solution; 5 is ginseng reference medicinal material solution; 6 is Kaixinsan test solution 1; 7 is Kaixinsan negative test solution 1. It can be seen that the development effect is not ideal. At the position corresponding to the reference medicinal material chromatogram, the main color spot is not clear, and the ginseng reference medicinal material interferes with the color development of the Polygala tenuifolia saponin spot.
[0074] Comparative Examples 1-3
[0075] The same method as in Example 1 was used to perform TLC identification on the indicative components in Polygala tenuifolia and Ginseng in Kaixin Powder, except that in the developing step, the developing agent was a mixed solution of dichloromethane-n-butanol-water in a mixed volume ratio of 13:7:2.
[0076] The results are as follows Figure 5 As shown, 1 is ginsenoside Rb1 reference solution; 2 is ginsenoside Re reference solution; 3 is polygala tenuifolia saponin reference solution; 4 is polygala tenuifolia reference medicinal material solution; 5 is ginseng reference medicinal material solution; 6 is Kaixinsan test solution 1; 7 is Kaixinsan negative test solution 1. It can be seen that the development effect is not ideal. At the position corresponding to the reference medicinal material chromatogram, the main color spot is blurred. Compared with the developing agent dichloromethane-n-butanol-water (volume ratio 7:4:1), the polygala tenuifolia saponin spot in Kaixinsan test sample is not obvious.
[0077] Comparative Examples 1-4
[0078] The same method as in Example 1 was used to perform TLC identification on the index components in Polygala tenuifolia and Ginseng in Kaixin Powder, except that during the spotting process, the spotting volume of reference solution 1 was 8 μL.
[0079] The results are as follows Figure 6 As shown, 1 is ginsenoside Rb1 reference solution; 2 is ginsenoside Re reference solution; 3 is Polygala tenuifolia saponin reference solution; 4 is Polygala tenuifolia reference medicinal material solution; 5 is ginseng reference medicinal material solution; 6 is Kaixinsan test solution 1; 7 is Kaixinsan negative test solution 1. It can be seen that at the position corresponding to the reference medicinal material chromatogram, the main color spot is blurred, and the spots of the same color are not clear;
[0080] In addition, the present invention also explores that when the sample volume of the reference solution is 4 μL, the results are displayed at the corresponding position of the reference medicinal material chromatogram, showing a main spot of the same color, but the spot of the Polygala tenuifolia saponin solution is lighter in color.
[0081] Example 2-1
[0082] The same method as in Example 2 was used to perform thin layer identification on the index components in Acorus calamus and Poria cocos in Kaixin Powder, except that in the developing step, the developing agent was a mixed solution of dichloromethane-ethyl acetate-formic acid with a mixing volume ratio of 12:3:0.25;
[0083] The results are as follows Figure 7 As shown, 1 is β-asarone reference solution; 2 is dehydrogenated tert-butyl acid reference solution; 3 is pachymic acid reference solution; 4 is pachycory reference medicinal material solution; 5 is Acorus tatarinowii reference medicinal material solution; 6 is Kaixinsan test solution 2; 7 is Kaixinsan negative test solution 2. It can be seen that at the position corresponding to the reference medicinal material chromatogram, the main spot of the same color is shown, and the spot color is clear, and the separation effect is good.
[0084] Comparative Example 2-1
[0085] The same method as in Example 2 was used to perform TLC identification on the indicative components in Acorus calamus and Poria cocos in Kaixin Powder, except that in the development step, the developing agent mixture used was a mixed solution of dichloromethane-ethyl acetate-formic acid in a ratio of 20:5:0.25.
[0086] The results are as follows Figure 8 As shown, 1 is β-asarone reference solution; 2 is dehydrogenated tert-butyl acid reference solution; 3 is pachymic acid reference solution; 4 is pachycory reference medicinal material solution; 5 is Acorus tatarinowii reference medicinal material solution; 6 is Kaixinsan test solution 2; 7 is Kaixinsan negative test solution 2. It can be seen that the main spot of the same color appears at the corresponding position of the reference medicinal material chromatogram, but the separation effect of β-asarone in the whole formula is not ideal.
[0087] Comparative Example 2-2
[0088] The same method as in Example 2 was used to perform thin layer identification on the indicative components in Acorus calamus and Poria cocos in Kaixin Powder, except that in the development step, the developing agent was a mixed solution of chloroform-ethyl acetate-formic acid with a mixing volume ratio of 12:3:0.5.
[0089] The results are as follows Fig. 9As shown, 1 is β-asarone reference solution; 2 is dehydrogenated tert-butyl acid reference solution; 3 is tuckahoe acid reference solution; 4 is tuckahoe reference medicinal material solution; 5 is calamus tatarinowii reference medicinal material solution; 6 is Kaixinsan test solution 2; 7 is Kaixinsan negative test solution 2. It can be seen that at the position corresponding to the reference medicinal material chromatogram, the main spot of the same color appears, but the spot of the dehydrogenated tert-butyl acid reference solution is not clear, and the separation effect of β-asarone in the whole formula is still not ideal.
[0090] Comparative Examples 2-3
[0091] The same method as in Example 2 was used to perform TLC identification on the index components in Acorus calamus and Poria cocos in Kaixin Powder, except that in the spotting step, the spotting volume of the reference solution 2 was 4 μL.
[0092] The results are as follows Fig.10 As shown, 1 is β-asarone reference solution; 2 is dehydrogenated tert-butyl acid reference solution; 3 is tuckahoe acid reference solution; 4 is tuckahoe reference medicinal material solution; 5 is calamus tatarinowii reference medicinal material solution; 6 is Kaixinsan test solution 2; 7 is Kaixinsan negative test solution 2. It can be seen that at the corresponding position of the reference medicinal material chromatogram, the main spot of the same color appears, but the spot of the dehydrogenated tert-butyl acid reference solution is lighter in color.
[0093] Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent substitutions for some of the technical features therein; and these modifications or substitutions do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A thin layer identification method for the index components in Kaixinsan. It is characterized in that The method comprises the following steps: A sample of Kaixinsan test solution 1, Kaixinsan negative test solution 1, reference medicinal material solution 1 and reference substance solution was respectively aspirated onto silica gel G thin layer plate 1 to determine the index components in ginseng and polygala; The Kaixinsan test solution 2, Kaixinsan negative test solution 2, reference medicinal material solution 2 and reference substance solution 2 were respectively sampled and spotted on silica gel G thin layer plate 2 to determine the index components in Poria cocos and Acorus tatarinowii. The silica gel G thin layer plate 1 is developed with dichloromethane-n-butanol-water as a developing solvent, and the silica gel G thin layer plate 2 is developed with dichloromethane-ethyl acetate-formic acid as a developing solvent. After development, the silica gel G thin layer plate 1 and the silica gel G thin layer plate 2 are taken out and dried; wherein the volume ratio of dichloromethane:n-butanol:water in the dichloromethane-n-butanol-water developing solvent is 7-8:4:1; the volume ratio of dichloromethane-ethyl acetate-formic acid in the dichloromethane-ethyl acetate-formic acid developing solvent is 12:3:0.25-0.5; After drying, the first silica gel G thin layer plate was sprayed with sulfuric acid ethanol solution for color development inspection, and after drying, the second silica gel G thin layer plate was sprayed with vanillin sulfuric acid ethanol mixed solution for color development inspection.
2. The thin layer identification method of the index component in Kaixinsan according to claim 1, It is characterized in that The indicative components in the ginseng and polygala include ginsenoside Rb1, ginsenoside Re and polygala tenuifolia saponin; The index components in the Poria cocos and Acorus tatarinowii include β-asarone, dehydrogenated turmeric acid and pachymic acid.
3. The thin layer identification method of the index component in Kaixinsan according to claim 1, It is characterized in that The Kaixin powder test solution 1 is a Kaixin powder solution with a mass volume ratio of 1 g / 10 mL dissolved by ultrasonication in 80-95% ethanol; The first negative test solution of Kaixinsan is a 1.5 g / 25 mL Acorus tatarinowii and Poria cocos solution dissolved by ultrasonication in 80-95% ethanol; wherein the mass volume ratios of Acorus tatarinowii and Poria cocos in the Acorus tatarinowii and Poria cocos solution are 0.5 g / 25 mL and 1 g / 25 mL respectively; The control medicinal material solution 1 includes a polygala control medicinal material solution and a ginseng control medicinal material solution, each of which has a mass volume ratio of 1 g / 50 mL and is ultrasonically dissolved in 80-95% ethanol; The reference solution one includes ginsenoside Rb1 reference solution, ginsenoside Re reference solution and polygala tenuifolia saponin reference solution, all of which are dissolved in methanol at a mass volume ratio of 1 mg / 1 mL.
4. The thin layer identification method of the index component in Kaixinsan according to claim 1, It is characterized in that The Kaixin powder test solution 2 is a Kaixin powder solution with a mass volume ratio of 1 g / 10 mL using dichloromethane ultrasonic dissolution; The second negative test solution of Kaixinsan is a ginseng and polygala solution with a mass volume ratio of 1 g / 25 mL dissolved by ultrasonication in dichloromethane; wherein the mass volume ratio of ginseng and polygala to the ginseng and polygala solution is 0.5 g / 25 mL; The second control medicinal material solution includes a control medicinal material solution of Acorus tatarinowii with a mass volume ratio of 1 g / 50 mL and a control medicinal material solution of Poria cocos with a mass volume ratio of 1 g / 25 mL, which are ultrasonically dissolved in dichloromethane; The second reference solution includes a β-asarone reference solution, a dehydrogenated tert-butyl ether reference solution and a pachymic acid reference solution dissolved in methanol at a mass volume ratio of 1 mg / 1 mL.
5. The thin layer identification method of the index component in Kaixinsan according to claim 1, It is characterized in that The sample volume ratio of Kaixinsan test solution 1, Kaixinsan negative test solution 1, reference medicinal material solution 1, and reference substance solution 1 is 15:15:8:6; The sample spotting volume ratio of Kaixinsan test solution 2, Kaixinsan negative test solution 2, control medicinal material solution 2, and reference substance solution 2 is 15:15:8:
6.
6. The thin layer identification method of the index component in Kaixinsan according to claim 1, It is characterized in that The mass percentage concentration of the sulfuric acid ethanol solution is 5%, wherein the volume ratio of the sulfuric acid solution to the ethanol solution is 1:
19.
7. The thin layer identification method of the index component in Kaixinsan according to claim 1, It is characterized in that The mass percentage concentration of the vanillin sulfuric acid ethanol mixed solution is 2%, wherein the volume ratio of the vanillin sulfuric acid solution to the ethanol solution is 1:
9.
8. The thin layer identification method of the index component in Kaixinsan according to claim 1, It is characterized in that The inspection conditions are daylight or 365nm ultraviolet light.
